Bridgecreek Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $783K | Hold |
2,225
| – | – | 0.15% | 61 |
|
|
2023
Q3 | $835K | Hold |
2,225
| – | – | 0.17% | 61 |
|
|
2023
Q2 | $851K | Hold |
2,225
| – | – | 0.16% | 64 |
|
|
2023
Q1 | $771K | Hold |
2,225
| – | – | 0.16% | 67 |
|
|
2022
Q4 | $524K | Hold |
2,225
| – | – | 0.12% | 74 |
|
|
2022
Q3 | $548K | Hold |
2,225
| – | – | 0.12% | 77 |
|
|
2022
Q2 | $673K | Hold |
2,225
| – | – | 0.14% | 74 |
|
|
2022
Q1 | $914K | Hold |
2,225
| – | – | 0.14% | 79 |
|
|
2021
Q4 | $1.04M | Sell |
2,225
-775
| -26% | -$334K | 0.14% | 70 |
|
|
2021
Q3 | $1.27M | Hold |
3,000
| – | – | 0.18% | 70 |
|
|
2021
Q2 | $1.08M | Hold |
3,000
| – | – | 0.16% | 71 |
|
|
2021
Q1 | $845K | Hold |
3,000
| – | – | 0.13% | 67 |
|
|
2020
Q4 | $850K | Hold |
3,000
| – | – | 0.13% | 66 |
|
|
2020
Q3 | $825K | Hold |
3,000
| – | – | 0.14% | 63 |
|
|
2020
Q2 | $682K | Hold |
3,000
| – | – | 0.13% | 65 |
|
|
2020
Q1 | $457K | Hold |
3,000
| – | – | 0.12% | 62 |
|
|
2019
Q4 | $451K | Hold |
3,000
| – | – | 0.08% | 85 |
|
|
2019
Q3 | $425K | Hold |
3,000
| – | – | 0.09% | 82 |
|
|
2019
Q2 | $375K | Hold |
3,000
| – | – | 0.08% | 83 |
|
|
2019
Q1 | $331K | Hold |
3,000
| – | – | 0.07% | 88 |
|
|
2018
Q4 | $294K | Hold |
3,000
| – | – | 0.08% | 82 |
|
|
2018
Q3 | $370K | Hold |
3,000
| – | – | 0.07% | 88 |
|
|
2018
Q2 | $298K | Hold |
3,000
| – | – | 0.06% | 94 |
|
|
2018
Q1 | $265K | Hold |
3,000
| – | – | 0.06% | 100 |
|
|
2017
Q4 | $296K | Hold |
3,000
| – | – | 0.07% | 91 |
|
|
2017
Q3 | $289K | Hold |
3,000
| – | – | 0.08% | 83 |
|
|
2017
Q2 | $284K | Hold |
3,000
| – | – | 0.08% | 85 |
|
|
2017
Q1 | $245K | Hold |
3,000
| – | – | 0.07% | 94 |
|
|
2016
Q4 | $254K | Sell |
3,000
-4,600
| -61% | -$362K | 0.07% | 92 |
|
|
2016
Q3 | $566K | Hold |
7,600
| – | – | 0.17% | 69 |
|
|
2016
Q2 | $577K | Hold |
7,600
| – | – | 0.18% | 69 |
|
|
2016
Q1 | $527K | Hold |
7,600
| – | – | 0.17% | 70 |
|
|
2015
Q4 | $458K | Hold |
7,600
| – | – | 0.15% | 71 |
|
|
2015
Q3 | $411K | Hold |
7,600
| – | – | 0.12% | 73 |
|
|
2015
Q2 | $441K | Hold |
7,600
| – | – | 0.11% | 81 |
|
|
2015
Q1 | $458K | Hold |
7,600
| – | – | 0.11% | 83 |
|
|
2014
Q4 | $405K | Hold |
7,600
| – | – | 0.11% | 81 |
|
|
2014
Q3 | $340K | Hold |
7,600
| – | – | 0.09% | 86 |
|
|
2014
Q2 | $321K | Hold |
7,600
| – | – | 0.09% | 90 |
|
|
2014
Q1 | $335K | Hold |
7,600
| – | – | 0.1% | 87 |
|
|
2013
Q4 | $373K | Hold |
7,600
| – | – | 0.11% | 84 |
|
|
2013
Q3 | $313K | Hold |
7,600
| – | – | 0.09% | 91 |
|
|
2013
Q2 | $267K | Buy |
+7,600
| New | +$250K | 0.09% | 86 |
|
Other funds holding WST
Bridgecreek Investment Management's WST Position: Q4 2023 in Review
Bridgecreek Investment Management held its West Pharmaceutical (WST) position steady in Q4 2023 at 2,225 shares worth $783K. The position accounts for 0.15% of the portfolio, ranked #61.
Bridgecreek Investment Management first reported a position in WST in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.27M in Q3 2021. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.
- Bridgecreek Investment Management held 2,225 shares of West Pharmaceutical worth $783K as of Q4 2023.
- Bridgecreek Investment Management left its West Pharmaceutical share count unchanged in Q4 2023.
- West Pharmaceutical made up 0.15% of Bridgecreek Investment Management's portfolio in Q4 2023, its #61 holding.
- Bridgecreek Investment Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 43 quarters since.
- Bridgecreek Investment Management's West Pharmaceutical position peaked at $1.27M in Q3 2021.
- 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.
Based on Bridgecreek Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.